Apoptin sensitizes radiation-induced cell death via classic mitochondrial, caspase and p53-dependent signaling in HepG2 cells
Authors:
Open Access
- 27 October 2010
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 4 (1) , 59-63
Abstract
Resistance or insensitivity to radiation therapy is one of the hallmarks of hepatocellular carcinoma. Sensitizing radioresistant cancer by combining radiation with other therapeutics to induce apoptosis has been widely investigated. Our previous study showed that chicken anaemia virus-derived apoptin protein induced the apoptosis of hepatic carcinoma HepG2 cells. In the present study, we demonstrated that apoptin sensitizes cells to radiation-induced apoptosis using a lentivirus-apoptin expression system in hepatic carcinoma HepG2 cells. Combination therapy with radiation and apoptin dramatically induced mitochondrial cytochrome c release and the cleavage of caspases -9, -3 and -7. Our findings are also the first to show that the combination of radiation and apoptin up-regulates p53 expression. Thus, apoptin treatment represents a potential method for enhancing the effectiveness of radiotherapy in poorly responding hepatocellular carcinoma.Keywords
This publication has 5 references indexed in Scilit:
- Expanded Criteria for Hepatocellular Carcinoma Through Down-Staging Prior to Liver Transplantation: Not Yet ThereSeminars in Liver Disease, 2006
- The role of Raf-1 in radiation resistance of human hepatocellular carcinoma Hep G2 cellsOncology Reports, 2004
- Targeting Apoptosis Pathways in Cancer TherapyCurrent Cancer Drug Targets, 2004
- Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patientsGastroenterology, 1993
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991